FECAL MICROBIOTA SIGNATURES ARE ASSOCIATED WITH DISEASE SEVERITY AND LOCATION IN INFLAMMATORY BOWEL DISEASE
Christopher Morehouse 1
Ben Sparklin 2
Antonio DiGiandomenico 2
Vancheswaran Gopalakrishnan 2
Bastian Angermann 3
Ulf Gehrmann 3
Jessica Neisen 4
Emon Khan 4
Junmei Cairns 4
1 AstraZeneca, Durham, United States
2 AstraZeneca, Gaithersburg, United States
3 AstraZeneca, Gothenburg, Sweden
4 AstraZeneca, Cambridge, United Kingdom
Topic
IBD
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]